Alinity chagas reagents for medical treatment facility

Ended Awarded Last action

Contract number
HT009026FG014
Awardee
Awarding agency
Obligated
$53,069

Award facts

Contract value 100% obligated
$53,068.69 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Chicago, IL 60064, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Abbott Laboratories Inc. (Abbott Diagnostics Division) on March 31, 2026, for Alinity Chagas reagents with a ceiling value of $53,068.69. The call is firm fixed price with an ultimate completion date of September 30, 2026. Place of performance is North Chicago, Illinois. No set-aside was used. The source does not identify the parent BPA by name or contracting agency.

Quick answers

Who was awarded contract HT009026FG014?

HT009026FG014 was awarded to Abbott Laboratories Inc. by Defense Health Agency (Department of Defense) on March 31, 2026.

How much is contract HT009026FG014 worth?

The government has obligated $53,069 on HT009026FG014.

Is contract HT009026FG014 an order under another contract?

Yes. HT009026FG014 is a BPA call under FA301624A0044, a blanket purchase agreement.

Was contract HT009026FG014 competed?

The extent of competition for HT009026FG014 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award